Evidence map›Paper›PMID 39344652›Full record

ArticleJournal of the American Heart Association2024

Prevalence, Characteristics, and Treatment Strategy of Different Types of Heart Failure in Patients With Nonvalvular Atrial Fibrillation.

Yulong Xia, Jie Jiang, Fangfang Fan, Yannan Pan, Jing Zhou, Yan Zhang, Jianping Li, Jun Liu, Na Yang, Yongchen Hao and 5 more

Registry-linked trialAbstract readMulticenter Study
In one paragraph

Article in Journal of the American Heart Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02309398 (Improving Care for Cardiovascular Disease in China), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02309398 completednot on this map

Improving Care for Cardiovascular Disease in China: A Collaborative Project of AHA and CSC (CCC Project) - Atrial Fibrillation

TypeobservationalSponsorBeijing Institute of Heart, Lung and Blood Vessel DiseasesRan2015 to 2020Enrolled67,028ConditionsAtrial Fibrillation
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. NovelBiomedicines · 2026
    Article
  2. Rare TruncatingGenes · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Discovery ofDiagnostics (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yulong XiaDepartment of Cardiovascular Disease Peking University First Hospital Beijing China.ORCID 0000-0002-2998-2074
Jie JiangDepartment of Cardiovascular Disease Peking University First Hospital Beijing China.ORCID 0000-0002-4077-0056
Fangfang FanDepartment of Cardiovascular Disease Peking University First Hospital Beijing China.ORCID 0000-0001-8351-4821
Yannan PanDepartment of Cardiovascular Disease Peking University First Hospital Beijing China.ORCID 0000-0003-4868-6649
Jing ZhouDepartment of Cardiovascular Disease Peking University First Hospital Beijing China.
Yan ZhangDepartment of Cardiovascular Disease Peking University First Hospital Beijing China.ORCID 0000-0002-7508-4160
Jianping LiDepartment of Cardiovascular Disease Peking University First Hospital Beijing China.ORCID 0000-0002-8526-1095
Jun LiuDepartment of Epidemiology, Beijing Anzhen Hospital Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases Beijing China.
Na YangDepartment of Epidemiology, Beijing Anzhen Hospital Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases Beijing China.ORCID 0000-0001-9022-171X
Yongchen HaoDepartment of Epidemiology, Beijing Anzhen Hospital Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases Beijing China.ORCID 0000-0002-6519-6185
Dong ZhaoDepartment of Epidemiology, Beijing Anzhen Hospital Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases Beijing China.ORCID 0000-0002-3239-3449
Jing LiuDepartment of Epidemiology, Beijing Anzhen Hospital Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases Beijing China.ORCID 0000-0002-3311-0818
Changsheng MaDepartment of Cardiology, Beijing Anzhen Hospital Capital Medical University Beijing China.ORCID 0000-0002-5387-5957
Yong HuoDepartment of Cardiovascular Disease Peking University First Hospital Beijing China.
CCC‐AF investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAtrial fibrillation (AF) is the most common arrhythmia in patients with heart failure (HF). Epidemiological data regarding HF in patients with AF are lacking. We describe the epidemiology, clinical features, treatment strategies, and in-hospital outcomes in patients with AF and HF. METHODS AND

resultsPatients with HF and nonvalvular AF in the Improving Care for Cardiovascular Disease in China-AF cohort from February 2015 to December 2019 were included. Patients were stratified by left ventricular ejection fraction into HF with reduced EF, HF with mildly reduced EF, and HF with preserved EF groups. The primary outcome was the occurrence of hospitalization for major adverse cardiovascular events, including death, cardiogenic shock, cardiac arrest, and stroke. Overall, 16 562 patients with AF and HF were included (mean age: 72.35±11.07 years; 46.1% female). HF with preserved EF (63.1%) accounted for the largest proportion, followed by HF with mildly reduced EF (19.0%) and HF with reduced EF (17.9%). Different HF subtypes in patients with AF had unique baseline demographic and clinical characteristics after multinomial logistic regression analysis. Compared with the HF with preserved EF group, hospitalization for major adverse cardiovascular events was increased in the HF with mildly reduced EF group (odds ratio=1.55 [95% CI, 1.18-2.03]) and HF with reduced EF group (odds ratio 1.60 [95% CI, 1.21-2.13]) after adjusting for confounders.

conclusionsIn this large Chinese AF registry, the distribution of HF differed from the non-AF population. Patients with AF with different types of HF have unique demographic and clinical characteristics. Occurrence rates of in-hospital outcomes were higher in patients with HF with mildly reduced EF and patients with HF with reduced EF compared with the HF with preserved EF group. REGISTRATION: URL: http://www.clinicaltrials.gov; Unique identifier: NCT02309398.

Indexed as

Atrial FibrillationHeart FailureStroke VolumeAgedAged, 80 and overChinaFemaleHospitalizationHumansMaleMiddle AgedPrevalenceRegistriesRisk FactorsVentricular Function, Leftatrial fibrillationepidemiologyheart failureoutcomesquality measures

Identifiers

PMID39344652
PMCPMC11681488

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.